Graham Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,997	Closed	-$394K	–	1330
2025 Q1	$394K	Buy	19,997 +4,819	+32%	+$94.8K	0.01%	872
2024 Q4	$342K	Buy	15,178 +6,106	+67%	+$137K	0.01%	851
2024 Q3	$232K	Buy	+9,072	New	+$232K	﹤0.01%	843